The OCM program is a good start on a path that is as rough as it gets in our healthcare system that needs reform, which can't come from legislation such as Obamacare.
Nash Gabrail, MD
Advertisement
Articles by Nash Gabrail, MD
Advertisement
Latest Updated Articles
The OCM Is Both Good and QuestionableNovember 7th 2016
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
3
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
4
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
5